CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 19 enrolled
Drug / intervention
Gabapentin +3 moredrug
Likely dose
Gabapentin 1200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01119222
NCT01119222Phase 1Completed

A Randomised, Double-Blind, Double-Dummy, Placebo And Active Controlled, 4-Way Crossover Methodology Study To Assess The Effect Of Gabapentin, Diphenhydramine And Morphine On Cold Pain In Healthy Male Volunteers

Pfizer·interventional·Posted May 7, 2010·Updated Mar 7, 2011

In Brief

A Phase 1 clinical trial evaluating Gabapentin, Diphenhydramine, and 2 other interventions for Healthy. Completed, enrolled 19 participants across 1 site.

Detailed Summary

Human experimental pain models are useful in understanding the mechanisms underlying clinical pain conditions and can be used to test the analgesic efficacy of drugs used in the management of pain. Once established these models can be used as mechanism biomarkers in early development clinical studies to establish proof of mechanism for novel compounds. The cold pain model is a mechanistic pain biomarker with potential application in proof of mechanism studies. In this study we aim to set up this cold pain model at a Clinical Research Unit and demonstrate we can effectively screen subjects for this model and examine the effect of morphine, diphenhydramine, and gabapentin in the cold pain model.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesBelgium
Collaborators--

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 7, 2010
Enrollment StartJul 1, 2008
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.2 years ago

Interventions

Gabapentindrug

Capsule, single 1200mg dose

Diphenhydraminedrug

Tablet, single 50mg dose

Morphinedrug

IV, single 10mg dose

Placebodrug

Placebo formulations (Capsule, tablet, IV to match the active treatments and to be administered in a double-dummy fashion).